Financial News · Live Terminal

Page 305 of 347

Barclays Lowers Price Target on Boston Scientific to $100 From $124, Maintains Overweight Rating

Boston Scientific (BSX) has an average rating of buy and mean price target of $97.23, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $61.58, Change: $+0.59, Percent Change: +0.97%

$BSX

Wire64d ago

Alto Neuroscience Starts Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression

Alto Neuroscience (ANRO) said Tuesday it has initiated a Phase 2b trial of its candidate ALTO-207 in treatment-resistant depression.The randomized, placebo-controlled study is designed to replicate positive results from the previous PAX-D study and streamline the drug's path toward regulatory registration, the company said. ALTO-207 is a novel, modified-release combination of pramipexole and ondansetron, according to the company.The formulation aims to reduce nausea typically associated with pramipexole, allowing for higher dosing and faster titration, the company said. In an earlier Phase 2a trial, the drug demonstrated a statistically significant improvement in depression symptoms, measured by the Montgomery-Asberg Depression Rating Scale, the company said.The trial will enroll about 178 adults in the US and UK who have failed multiple prior treatments, the company said. The primary goal is to measure changes in depression scores over an eight-week treatment period, and topline data are expected in H2 of 2027, the company said.Price: $25.08, Change: $-2.26, Percent Change: -8.25%

$ANRO

Wire64d ago

Amazon Launches GLP-1 Management Program Under One Medical

Amazon (AMZN) said Tuesday that launched a GLP-1 management program through Amazon One Medical.The company said the program is designed to integrate GLP-1 management into primary care, pharmacy services through Amazon Pharmacy, and virtual care options. Amazon Pharmacy offers GLP-1 treatments such as Wegovy and Foundayo oral GLP-1 pills, Amazon added.AMZN shares were up 1.8% in early trading Tuesday.Price: $252.72, Change: $+4.44, Percent Change: +1.79%

$AMZN

Wire64d ago

Amazon Launches GLP-1 Weight-Management Program

Amazon (AMZN) said Tuesday it has launched a GLP-1 Management Program through Amazon One Medical that provides primary care, pharmacy services and virtual care options to help patients achieve and maintain their weight-loss goals.Amazon said its pharmacy is offering oral GLP-1 pills starting as low as $25 per month with insurance coverage or cash-pay options starting at $149 per month.Price: $252.30, Change: $+4.02, Percent Change: +1.62%

$AMZN

Wire64d ago

Nike Picked Stock of the Week at Smart Insider Following Renewed Insider Buying

Nike (NKE) was named Smart Insider's stock pick of the week after insider purchases resumed following a recent decline in the share price.Smart Insider said it previously ranked the stock +1 on Dec. 24 after a $3 million share purchase by Lead Independent Director Timothy Cook at $59 per share, alongside $500,000 purchases each from directors Robert Swan and Jorgen Knudstorp.Chief Executive Elliott Hill also spent $1 million in December following the upgrade, according to Smart Insider.After reporting Q3 results on March 31, the stock has fallen about 25% since December, Smart Insider said, adding that insiders responded with additional purchases totaling about $2.7 million between April 7 and April 13 at around $43 per share.John Rogers, a director since 2018, bought $173,000 of shares in his first purchase since December 2024, according to the report. Hill acquired another $1 million of stock, Cook added $1.1 million to his holdings, and Swan purchased $500,000 of shares, Smart Insider said.Smart Insider said that while the December buying was not timely, the recent cluster of purchases is encouraging.Smart Insider renewed its +1 rating on the stock, indicating a strong positive signal.Price: $46.93, Change: $+0.45, Percent Change: +0.97%

$NKE

Wire64d ago

Teradyne Says Preliminary Injunction Issued Against Elite Robots in Copyright Infringement Case

Teradyne's (TER) Teradyne Robotics unit said Tuesday the Regional Court of Hamburg has issued a preliminary injunction prohibiting Elite Robots Germany from offering or distributing allegedly infringing software until further notice.Elite Robots Germany was also ordered to provide information about the allegedly infringing acts it has committed and the clients it has supplied, Teradyne Robotics said, adding it aims to take legal action against Elite Robots' distributors and partners that will continue to offer the allegedly infringing software.Teradyne Robotics in February sued Elite Robots Germany over alleged copyright infringement of software belonging to Teradyne's Universal Robots.Elite Robots didn't immediately respond to a request for comment by.Price: $384.39, Change: $+9.18, Percent Change: +2.45%

$TER

Wire64d ago

Polaryx Says PLX-200 Granted FDA Fast Track Designations for Neurodegenerative Conditions

Polaryx Therapeutics (PLYX) said Tuesday the US Food and Drug Administration granted Fast Track designation to PLX-200 to potentially treat neurodegenerative conditions, including juvenile neuronal ceroid lipofuscinosis, krabbe disease, and sandhoff disease.The designation allows for more frequent interaction with the agency and the possibility of a rolling review for a future marketing application, the company said.Polaryx said PLX-200 now holds Fast Track designation for all four prospective indications that are a part of the SOTERIA phase 2 basket trial. It secured the designation to treat late-infantile neuronal ceroid lipofuscinosis disease in March.Shares of the company were down over 7% in Tuesday's trading.Price: $5.38, Change: $-0.32, Percent Change: -5.65%

$PLYX

Wire64d ago

HII Signs on to Framework for Collaboration With Applied Intuition For Naval Artificial Intelligence Systems

HII (HII) said Tuesday it signed a memorandum of understanding with artificial intelligence firm Applied Intuition to develop advanced software systems for next-generation naval vessels.The agreement establishes a framework to collaborate on an AI operating system designed to enhance maritime platform performance and scale autonomous features across crewed and uncrewed ships, the company said.The businesses will initially focus on integrating the commercial software into the upcoming Romulus line of uncrewed surface vessels currently being built in Louisiana, HII said.Shares of the company were down 1.8% in Tuesday trading.Price: $384.96, Change: $-7.23, Percent Change: -1.84%

$HII

Wire64d ago

NeoVolta Lifts Stake in US Battery Joint Venture to 80%

NeoVolta (NEOV) increased its ownership in NeoVolta Power, its US battery energy storage system manufacturing joint venture in Pendergrass, Georgia, to 80% from 60%.The remaining 20% will continue to be held by CCC, a US subsidiary of PotisEdge, NeoVolta said Tuesday in a statement.The transaction requires no new cash outlay. NeoVolta said.NeoVolta retains full board and operational control of the venture, and the updated structure is designed to align with US manufacturing incentive frameworks.The company also entered into a sales, marketing, and business development agreement with PotisEdge and agreed to issue 1.2 million common shares as consideration.Price: $3.10, Change: $-0.02, Percent Change: -0.64%

$NEOV

Wire64d ago

Moderna Says European Commission Grants Marketing Authorization for mCombriax Vaccine for Influenza, COVID-19

Moderna (MRNA) said Tuesday the European Commission has granted marketing authorization for its mCombriax vaccine for the prevention of influenza and COVID-19 caused by SARS-CoV-2 in individuals 50 years of age and older.The marketing authorization is valid in all 27 European Union member states, as well as Iceland, Liechtenstein and Norway, Moderna said.The Commission's authorization is based on the results from the phase 3 clinical study evaluating the safety, reactogenicity, and immunogenicity of mCombriax in two independent age groups of about 4,000 adults each, Moderna said.Price: $54.02, Change: $-0.57, Percent Change: -1.04%

$MRNA

Wire64d ago

Allogene Therapeutics Cleared to Expand B-Cell Lymphoma Treatment Trial in South Korea, Australia

Allogene Therapeutics (ALLO) said Tuesday it has received clearance from regulators in South Korea and Australia to expand its pivotal phase 2 study evaluating cemacabtagene ansegedleucel in first-line consolidation treatment for patients with large B-cell lymphoma into those two countries.With the clearances, the study is set to expand to more than 80 global sites from more than 60 sites currently in North America, the company said.The study is expected to enroll about 220 patients by the end of 2027, with an interim analysis of event-free survival anticipated in mid-2027 and the primary analysis in mid-2028, according to a statement.Positive results from the study could support a biologics license application submission, Allogene said.Price: $2.31, Change: $-0.12, Percent Change: -4.75%

$ALLO

Wire64d ago

Evercore ISI Adjusts Molson Coors Beverage Price Target to $47 From $50, Maintains Outperform Rating

Molson Coors Beverage (TAP) has an average rating of Hold and mean price target of $46.55, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $44.01, Change: $-0.28, Percent Change: -0.64%

$TAP

Wire64d ago

Amazon Launches GLP-1 Weight-Management Program

$AMZN

Wire64d ago

Critical Metals Launches Private Placement of Common Shares

Critical Metals (CRML) said Tuesday it launched a private placement of nearly 6 million common shares at $10 apiece for gross proceeds of $60 million.The offering is expected to close on Wednesday, according to a statement.Net proceeds will be used for working capital, including the development of the Tanbreez project, the company said.Price: $11.26, Change: $-0.68, Percent Change: -5.70%

$CRML

Wire64d ago

Parke Bancorp Increases Dividend to be Declared for Q2 to $0.20 From $0.18

$PKBK

Wire64d ago

Voyager Technologies Collaborates With Yonsei University to Advance VISTA Ecosystem

Voyager Technologies (VOYG) said Tuesday it signed a memorandum of understanding with Yonsei University in South Korea to advance the Voyager Institute for Space, Technology and Advancement, or VISTA, science park ecosystem, located in Ohio State University.The company said the agreement brings Yonsei University's talent and research capacity into the VISTA ecosystem. Voyager and Yonsei University aim to develop research programs and applications for public and private sector use, the company added.Shares of Voyager were up more than 6% in Tuesday trading.Price: $33.59, Change: $+2.01, Percent Change: +6.35%

$VOYG

Wire64d ago

Morgan Stanley Adjusts Price Target on VICI Properties to $38 From $35, Maintains Equalweight Rating

VICI Properties (VICI) has an average rating of overweight and mean price target of $34.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $28.79, Change: $+0.01, Percent Change: +0.03%

$VICI

Wire64d ago

Jefferies Adjusts Price Target on FirstEnergy to $52 From $50, Maintains Hold Rating

FirstEnergy (FE) has an average rating of overweight and mean price target of $53.46, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $49.10, Change: $-0.35, Percent Change: -0.71%

$FE

Wire64d ago

Unusual Machines Obtains $5 Million-Plus Order From Powerus for Counter-UAS Systems

Unusual Machines (UMAC) said Tuesday it received an order worth more than $5 million to supply U.S.-made components for counter-UAS systems and related drone platforms to Autonomous Power, doing business as Powerus.Deliveries are scheduled to begin in April and are expected to be completed within the second quarter, Unusual Machines said.Price: $15.70, Change: $+0.26, Percent Change: +1.68%

$UMAC

Wire64d ago

Cognizant Forms Partnership With OpenAI to Integrate Codex Technology

Cognizant (CTSH) said Tuesday it collaborated with Microsoft-backed (MSFT) OpenAI to distribute the Codex artificial intelligence model to enterprise clients globally.The business is integrating the technology into its internal engineering procedures to establish it as a standard mechanism for all software production, the company said.Developers are actively using the system during client projects to build machine learning models and restructure existing code, Cognizant said.The current implementations aim to speed up project completion times while decreasing the financial burden and complications tied to massive corporate system upgrades, it said.Shares of the company were up 1.8% in Tuesday trading.Price: $61.24, Change: $+0.98, Percent Change: +1.63%

$CTSH$MSFT

Showing 6081-6100 of 6934